What may be driving it
The specific mutations, copy-number changes, fusions, and expression, ranked by how strong the evidence is.
flip ↷Strong findings kept separate from uncertain signals, so nothing gets overstated.
My cancer overexpresses DLL3. That's immunosuppressive, but it also gives you something to aim at. Finding it stopped me trusting the report as the last word. I took what I found to my oncologists and asked what else we should be looking at. I didn't act on any of it alone.
Built for that moment, by someone who needed it himself. One person's experience; not a promise of findings for anyone.
Sequencing, genomics reports, labs, pathology — no bioinformatics needed.
Your DNA, RNA, and immune signals are analyzed; AI summarizes the results.
One report your oncologist can read fast, with the solid findings kept separate from the shaky ones.
A real report from the founder's own cancer data. Open it before you pay — yours reads differently, but the structure is the same.
Your files run through the open-source tools cancer labs use, aligned to GRCh38: Mutect2, VEP, STAR, MHCflurry, DepMap and more. Then AI weighs what came out and writes it up in plain English, with a source behind every claim.
Mutect2MuSEVEPSTARSalmonArribaPureCNFACETSOptiTypeMHCflurryDepMaptrialsevidence-weightedcitedMore data means a deeper analysis — but you don't need to understand the formats. Most hospitals release your files on request.
A cancer genomics report from your hospital or testing company.
VCF · BAM · CRAM · FASTQ plus matched normal data, which enables germline findings.
Anything describing the diagnosis, tissue, markers, or treatments.
It's encrypted in transit and at rest, analyzed only in our own pipeline, and you can delete it permanently whenever you want.
Read the privacy policy →One-time fee, no subscription. Most reports are ready within a few days. Read the full sample report before you pay.
Analysis from your existing genomics report.
The complete pipeline on your raw sequencing files.
VCF · BAM · CRAM · FASTQEverything in Full, plus a 1:1 walkthrough of your report.
Read the full sample report free before you decide. One-time fee, no subscription; full refund if we can't process your files.
Checkout and upload happen on our secure analysis portal.
Not sure it fits your case? Email me before you upload.
No — an educational and research tool, not a medical device, diagnosis, or treatment plan. Review every finding with your oncology team before acting.
No. Your files run through a real genomics pipeline built on the open tools cancer labs use: Mutect2, MuSE, VEP, STAR, MHCflurry, DepMap. Mutations only count when two separate callers agree on them. AI comes in at the end to weigh the results and write them up, and every claim points back to its source.
It's analyzed in our own pipeline — not handed to a third party to do the genomics. Never sold, shared, or used to train AI, and you can delete it permanently at any time.
If you include matched normal-tissue data, it can surface inherited (germline) signals that may affect blood relatives — and rarely, unexpected family relationships. It isn't designed to diagnose inherited conditions; confirm any inherited finding with a genetic counselor.
Existing tumor sequencing — ideally with matched normal data — plus any lab or pathology reports. It analyzes data you already have; it doesn't generate new sequencing.
The pipeline runs automatically once your files are uploaded. Most reports are ready within a few days; we email you when yours is done.
Some cases carry fewer signals. The report still organizes what's there and flags the gaps — no finding is ever guaranteed, and that honesty is the point.
Full refund if your files can't be processed. Once a report is generated the fee is non-refundable, since the analysis has run — which is why the complete sample is here to read first.
Read the free sample, then run it on your own files.
Triangle Health is an educational and research tool — not a medical device, a diagnosis, or a substitute for professional medical advice, and not FDA-cleared. Always review any finding, treatment idea, or research-stage suggestion with your oncology team before acting.
Write if the experience, the data, or the tool overlaps with something you are trying to understand.